Reference: SARS-CoV-2 positivity rates associated with circulating 25- hydroxyvitamin D level. PloS ONE 2020; 15:e0239252
Until treatment and vaccine for coronavirus disease-2019 (COVID-19) becomes widely available, other methods of reducing infection rates should be explored. This study used a retrospective, observational analysis of deidentified tests performed at a national clinical laboratory to determine if circulating 25-hydroxyvitamin D (25(OH)D) levels are associated with severe acute respiratory disease coronavirus 2 (SARS-CoV-2) positivity rates.
Tags: 25-hydroxyvitamin D, RNA, Vitamin D